<p>As outlined in the published final package of, ‘Community Pharmacy in 2016/17 and beyond’<sup>1</sup>, the Government is committed to pursuing a number of reimbursement reforms and taking steps to improve the prescription ordering journey to maximise patient choice and convenience.</p><p> </p><p>The reimbursement reforms include:</p><p>- ‘non Part VIII’ products, i.e. products with no reimbursement price listed in Part VIII of the Drug Tariff;</p><p>- changes to Category M for certain generic medicines to better reflect their market price;</p><p>- changes to the margin survey to account for multiple suppliers for Non Part VIII products and Category C products;</p><p>- ‘splitting the discount’- to reflect that in general generic medicines have increased margin over brands; and</p><p>- changes to the way Category A prices are set.</p><p>The Government has also recently committed to reforming reimbursement arrangements for specials.</p><p> </p><p>Note:</p><p><sup>1</sup><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/561495/Community_pharmacy_package_A.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/561495/Community_pharmacy_package_A.pdf</a></p>